Approximately 60% of all ischemic strokes are believed to be due to emboli. It is well established that the risk of embolic stroke increases with age. Although certain underlying conditions have been associated with a higher risk of embolism, the majority of embolic strokes occur in patients for whom no definite cause can be identified. Thus, it is imperative that markers of stroke risk be developed for this particular mechanism of cerebral infarction. In order to identify markers of embolic stroke risk, it is logical to focus on the hemostatic system, which regulates clot formation. Fibrinogen and von Willebrand factor (vWF) levels have been associated with a higher risk of ischemic stroke, and are elevated in highrisk cardiac conditions, such as atrial fibrillation. Recently, polymorphisms in the genes encoding vWF, fibrinogen, and factor XIII have been identified and linked to thrombotic events. These polymorphisms increase circulating levels of vWF and fibrinogen, respectively, and contribute to the formation of unstable thrombus due to ineffective fibrinogen to factor XIII crosslinking. In addition, a polymorphism of factor XHI has been identified, which increases its enzymatic activity and appears to result in the formation of unstable clot. The proposed project is a 5year, casecontrol study at a single academic medical center collecting genetic material and factor levels on consecutive cases of embolic stroke, nonembolic stroke, nonstroke controls.
The Specific Aims of this project are to: 1) test the hypothesis that the allele frequencies for polymorphisms in the genes encoding vWF, fibrinogen, and factor XIII are higher in patients with embolic stroke than in nonembolic stroke subtypes or nonstroke controls, 2) test the hypothesis that the levels of vWF and fibrinogen will increase with age and that there will be an interaction between age and allele status affecting the vWF and fibrinogen levels, 3) establish the effects of conventional stroke risk factors on the expression of polymorphisms in the vWF, fibrinogen, and factor XIII genes, and 4) determine whether there is an association between allele status in the vWF, fibrinogen, and factor XIII polymorphisms and short-term death or recurrent stroke.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23NS042720-04
Application #
6824896
Study Section
NST-2 Subcommittee (NST)
Program Officer
Jacobs, Tom P
Project Start
2002-02-15
Project End
2006-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
4
Fiscal Year
2005
Total Cost
$170,578
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Ay, Hakan; Arsava, Ethem Murat; Andsberg, Gunnar et al. (2014) Pathogenic ischemic stroke phenotypes in the NINDS-stroke genetics network. Stroke 45:3589-96
Meschia, James F; Arnett, Donna K; Ay, Hakan et al. (2013) Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes. Stroke 44:2694-702
Holliday, Elizabeth G; Maguire, Jane M; Evans, Tiffany-Jane et al. (2012) Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet 44:1147-51
Hwang, David Y; Silva, Gisele S; Furie, Karen L et al. (2012) Comparative sensitivity of computed tomography vs. magnetic resonance imaging for detecting acute posterior fossa infarct. J Emerg Med 42:559-65
Biffi, Alessandro; Anderson, Christopher D; Nalls, Michael A et al. (2010) Principal-component analysis for assessment of population stratification in mitochondrial medical genetics. Am J Hum Genet 86:904-17
Jimenez-Conde, Jordi; Biffi, Alessandro; Rahman, Rosanna et al. (2010) Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke 41:437-42
Ramoni, Rachel Badovinac; Himes, Blanca E; Sale, Michele M et al. (2009) Predictive genomics of cardioembolic stroke. Stroke 40:S67-70
Kelly, Peter J; Morrow, Jason D; Ning, MingMing et al. (2008) Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke 39:100-4
Ning, M; Furie, K L; Koroshetz, W J et al. (2006) Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke. Neurology 66:1550-5
Furie, Karen L; Kelly, Peter J (2006) Homocyst(e)ine and stroke. Semin Neurol 26:24-32

Showing the most recent 10 out of 12 publications